{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:48:58Z","timestamp":1791938938170,"version":"4.3.4"},"reference-count":144,"publisher":"The Royal Society","issue":"10","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Heat shock protein 90 (Hsp90) is a ubiquitous molecular chaperone that governs the folding, stabilization and activity of a wide range of client proteins, many of which are critical regulators of immune cell signalling and inflammatory responses. Recent research has underscored the role of Hsp90 in orchestrating both innate and adaptive immune functions, particularly in the context of autoimmune diseases. In autoimmune diseases, dysregulated immune pathways often involve Hsp90-dependent client proteins, including key kinases and transcription factors. By modulating the activation, differentiation and survival of immune cells Hsp90 emerges as a central node in autoimmune pathogenesis. Importantly, the pharmacological inhibition of Hsp90 has shown promise in preclinical models of autoimmunity, where it attenuates pro-inflammatory pathways. In this review, we examine the immunoregulatory functions of Hsp90 with a focus on autoimmune disorders, highlighting its role in disease-driving pathways, such as Nuclear Factor Kappa B (NF-\u03baB), Janus Kinase\/Signal Transducer and Activator of Transcription (JAK\/STAT) and Mitogen-Activated Protein Kinase (MAPK). We also discuss the current landscape of Hsp90 inhibitors, their mechanism of action, and emerging data on their efficacy in autoimmune disease models. Understanding how Hsp90 shapes immune cell behaviour and inflammation provides a compelling framework for its development as a novel therapeutic target in chronic autoimmune conditions.<\/jats:p>","DOI":"10.1098\/rsob.260040","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:06:57Z","timestamp":1791936417000},"source":"Crossref","is-referenced-by-count":0,"title":["Hsp90 as a master regulator in autoimmunity: from cellular stress to clinical opportunity"],"prefix":"10.1098","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8128-8426","authenticated-orcid":false,"given":"Scott","family":"Scarneo","sequence":"first","affiliation":[{"name":"Department of Research and Development, Eydis Bio Inc 1 , Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Freeze","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Eydis Bio Inc 1 , Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy A.","family":"Haystead","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Eydis Bio Inc 1 , Durham, NC, USA"},{"name":"Department of Pharmacology and Cancer Biology, Duke University School of Medicine 2 , Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"175","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"2026101320065187600_RSOB260040C1","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1007\/PL00012491","article-title":"Heat-shock protein 90, a chaperone for folding and regulation","volume":"59","author":"Picard","year":"2002","journal-title":"Cell. Mol. Life Sci."},{"key":"2026101320065187600_RSOB260040C2","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/febs.12147","article-title":"Hsp90, an unlikely ally in the war on cancer","volume":"280","author":"Barrott","year":"2013","journal-title":"FEBS J."},{"key":"2026101320065187600_RSOB260040C3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc1716","article-title":"HSP90 and the chaperoning of cancer","volume":"5","author":"Whitesell","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"2026101320065187600_RSOB260040C4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/128_2012_356","article-title":"Hsp90: structure and function","volume":"328","author":"Jackson","year":"2012","journal-title":"Top. Curr. Chem."},{"key":"2026101320065187600_RSOB260040C5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0959-440X(99)00047-0","article-title":"Structure and in vivo function of Hsp90","volume":"10","author":"Pearl","year":"2000","journal-title":"Curr. Opin. Struct. Biol."},{"key":"2026101320065187600_RSOB260040C6","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1046\/j.1432-1033.2003.03610.x","article-title":"Comparative analysis of the ATP-binding sites of Hsp90 by nucleotide affinity cleavage: a distinct nucleotide specificity of the C-terminal ATP-binding site","volume":"270","author":"Soti","year":"2003","journal-title":"Eur. J. Biochem."},{"key":"2026101320065187600_RSOB260040C7","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1074\/jbc.273.6.3679","article-title":"Hop modulates Hsp70\/Hsp90 interactions in protein folding","volume":"273","author":"Johnson","year":"1998","journal-title":"J. Biol. Chem."},{"key":"2026101320065187600_RSOB260040C8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1158\/1535-7163.MCT-07-0484","article-title":"A novel Hsp90 inhibitor to disrupt Hsp90\/Cdc37 complex against pancreatic cancer cells","volume":"7","author":"Zhang","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"2026101320065187600_RSOB260040C9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/med.21807","article-title":"Targeting the Hsp90-CDC37-kinase chaperone cycle: a promising therapeutic strategy for cancer","volume":"42","author":"Wang","year":"2022","journal-title":"Med. Res. Rev."},{"key":"2026101320065187600_RSOB260040C10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nri749","article-title":"Roles of heat-shock proteins in innate and adaptive immunity","volume":"2","author":"Srivastava","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"2026101320065187600_RSOB260040C11","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.4049\/jimmunol.1200593","article-title":"Heat shock protein 90 is critical for regulation of phenotype and functional activity of human T lymphocytes and NK cells","volume":"190","author":"Bae","year":"2013","journal-title":"J. Immunol."},{"key":"2026101320065187600_RSOB260040C12","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S1471-4914(02)02316-X","article-title":"Hsp90 inhibitors as novel cancer chemotherapeutic agents","volume":"8","author":"Neckers","year":"2002","journal-title":"Trends Mol. Med."},{"key":"2026101320065187600_RSOB260040C13","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2174\/156802609789895728","article-title":"Update on Hsp90 inhibitors in clinical trial","volume":"9","author":"Kim","year":"2009","journal-title":"Curr. Top. Med. Chem."},{"key":"2026101320065187600_RSOB260040C14","doi-asserted-by":"crossref","first-page":"18 091","DOI":"10.1038\/s41598-022-22788-8","article-title":"Expression of membrane Hsp90 is a molecular signature of T cell activation","volume":"12","author":"Scarneo","year":"2022","journal-title":"Sci. Rep."},{"key":"2026101320065187600_RSOB260040C15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature01913","article-title":"A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors","volume":"425","author":"Kamal","year":"2003","journal-title":"Nature"},{"key":"2026101320065187600_RSOB260040C16","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1016\/S1470-2045(13)70169-4","article-title":"Inhibition of Hsp90 molecular chaperones: moving into the clinic","volume":"14","author":"Garcia-Carbonero","year":"2013","journal-title":"Lancet Oncol."},{"key":"2026101320065187600_RSOB260040C17","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cstres.2024.05.005","article-title":"An update on the status of Hsp90 inhibitors in cancer clinical trials","volume":"29","author":"Rastogi","year":"2024","journal-title":"Cell Stress Chaperones"},{"key":"2026101320065187600_RSOB260040C18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.lungcan.2021.10.001","article-title":"Phase 1 multicenter study of the Hsp90 inhibitor SNX-5422 plus carboplatin and paclitaxel in patients with lung cancers","volume":"162","author":"Gutierrez","year":"2021","journal-title":"Lung Cancer"},{"key":"2026101320065187600_RSOB260040C19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/978-1-4939-7477-1_29","article-title":"Clinical evaluation and biomarker profiling of Hsp90 inhibitors","volume":"1709","author":"Yuno","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"2026101320065187600_RSOB260040C20","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.annonc.2022.05.518","article-title":"Pimitespib in patients with advanced gastrointestinal stromal tumor (CHAPTER-GIST-301): a randomized, double-blind, placebo-controlled phase III trial","volume":"33","author":"Kurokawa","year":"2022","journal-title":"Ann. Oncol."},{"key":"2026101320065187600_RSOB260040C21","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s10637-019-00889-y","article-title":"A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancer","volume":"38","author":"Goyal","year":"2020","journal-title":"Invest. New Drugs"},{"key":"2026101320065187600_RSOB260040C22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13058-017-0879-5","article-title":"A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer","volume":"19","author":"Jhaveri","year":"2017","journal-title":"Breast Cancer Res."},{"key":"2026101320065187600_RSOB260040C23","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1158\/1078-0432.CCR-18-3212","article-title":"Pharmacodynamic and clinical results from a phase I\/II study of the Hsp90 inhibitor Onalespib in combination with abiraterone acetate in prostate cancer","volume":"25","author":"Slovin","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"2026101320065187600_RSOB260040C24","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.freeradbiomed.2010.03.001","article-title":"Reactive oxygen species mediate hepatotoxicity induced by the Hsp90 inhibitor geldanamycin and its analogs","volume":"48","author":"Samuni","year":"2010","journal-title":"Free Radical Biol. Med."},{"key":"2026101320065187600_RSOB260040C25","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/cncr.29339","article-title":"Phase 1\/1B trial of the heat shock protein 90 inhibitor NVP-AUY922 as monotherapy or in combination with bortezomib in patients with relapsed or refractory multiple myeloma","volume":"121","author":"Seggewiss-Bernhardt","year":"2015","journal-title":"Cancer"},{"key":"2026101320065187600_RSOB260040C26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.taap.2013.09.018","article-title":"A rat retinal damage model predicts for potential clinical visual disturbances induced by Hsp90 inhibitors","volume":"273","author":"Zhou","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"2026101320065187600_RSOB260040C27","first-page":"1849","article-title":"Ganetespib: research and clinical development","volume":"8","author":"Jhaveri","year":"2015","journal-title":"OncoTargets Ther."},{"key":"2026101320065187600_RSOB260040C28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fonc.2018.00064","article-title":"A phase Ib\/II study of ganetespib with doxorubicin in advanced solid tumors including relapsed-refractory small cell lung cancer","volume":"8","author":"Subramaniam","year":"2018","journal-title":"Front. Oncol."},{"key":"2026101320065187600_RSOB260040C29","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1158\/1078-0432.CCR-12-3381","article-title":"A multicenter phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancer","volume":"19","author":"Socinski","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"2026101320065187600_RSOB260040C30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41467-017-00449-z","article-title":"Hsp90 inhibition enhances cancer immunotherapy by upregulating interferon response genes","volume":"8","author":"Mbofung","year":"2017","journal-title":"Nat. Commun."},{"key":"2026101320065187600_RSOB260040C31","first-page":"63","article-title":"Efficacy and safety of the heat shock protein 90 inhibitor RGRN-305 in hidradenitis suppurativa: a parallel-design double-blind trial","volume":"160","author":"Ben Abdallah","year":"2024","journal-title":"J. Am. Med. Assoc. Dermatol."},{"key":"2026101320065187600_RSOB260040C32","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/bjd.20880","article-title":"Hsp90 inhibitor RGRN-305 for oral treatment of plaque-type psoriasis: efficacy, safety and biomarker results in an open-label proof-of-concept study","volume":"186","author":"Bregnhoj","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"2026101320065187600_RSOB260040C33","doi-asserted-by":"crossref","first-page":"563","DOI":"10.4049\/jimmunol.1000222","article-title":"EC144, a synthetic inhibitor of heat shock protein 90, blocks innate and adaptive immune responses in models of inflammation and autoimmunity","volume":"186","author":"Yun","year":"2011","journal-title":"J. Immunol."},{"key":"2026101320065187600_RSOB260040C34","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1002\/art.24047","article-title":"Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis","volume":"58","author":"Rice","year":"2008","journal-title":"Arthritis Rheum."},{"key":"2026101320065187600_RSOB260040C35","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/j.pain.0000000000002511","article-title":"Expression of ectopic heat shock protein 90 in male and female primary afferent nociceptors regulates inflammatory pain","volume":"163","author":"Wang","year":"2022","journal-title":"Pain"},{"key":"2026101320065187600_RSOB260040C36","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1007\/s10787-026-02265-8","article-title":"RGRN-305, a novel Hsp90 inhibitor: a promising therapeutic option for inflammatory dermatologic diseases","volume":"34","author":"Heidari","year":"2026","journal-title":"Inflammopharmacology"},{"key":"2026101320065187600_RSOB260040C37","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s11427-021-2187-3","article-title":"Innate and adaptive immune abnormalities underlying autoimmune diseases: the genetic connections","volume":"66","author":"Chi","year":"2023","journal-title":"Sci. China Life Sci."},{"key":"2026101320065187600_RSOB260040C38","doi-asserted-by":"crossref","first-page":"e01124","DOI":"10.1002\/prp2.1124","article-title":"Delineation of the distinct inflammatory signaling roles of TAK1 and JAK1\/3 in the CIA model of rheumatoid arthritis","volume":"11","author":"Freeze","year":"2023","journal-title":"Pharmacol. Res. Perspect."},{"key":"2026101320065187600_RSOB260040C39","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.2147\/JPR.S451409","article-title":"Transforming growth factor-beta-activated kinase 1 (TAK1) alleviates inflammatory joint pain in osteoarthritis and gouty arthritis preclinical models","volume":"17","author":"Freeze","year":"2024","journal-title":"J. Pain Res."},{"key":"2026101320065187600_RSOB260040C40","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/pmic.200700249","article-title":"Proteomic analysis of human osteoarthritic chondrocytes reveals protein changes in stress and glycolysis","volume":"8","author":"Ruiz-Romero","year":"2008","journal-title":"Proteomics"},{"key":"2026101320065187600_RSOB260040C41","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.4161\/cc.3.12.1277","article-title":"Hsp90 activation and cell cycle regulation","volume":"3","author":"Burrows","year":"2004","journal-title":"Cell Cycle"},{"key":"2026101320065187600_RSOB260040C42","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41523-022-00493-z","article-title":"Safety and efficacy of Hsp90 inhibitor ganetespib for neoadjuvant treatment of stage II\/III breast cancer","volume":"8","author":"Lang","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"2026101320065187600_RSOB260040C43","first-page":"1","article-title":"Hsp90 inhibitors and cancer: prospects for use in targeted therapies (review)","volume":"49","author":"Li","year":"2023","journal-title":"Oncol. Rep."},{"key":"2026101320065187600_RSOB260040C44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0065-2776(04)86004-8","article-title":"Innate autoimmunity","volume":"86","author":"Carroll","year":"2005","journal-title":"Adv. Immunol."},{"key":"2026101320065187600_RSOB260040C45","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1016\/j.febslet.2008.10.053","article-title":"Hsp90 is required for TAK1 stability but not for its activation in the pro-inflammatory signaling pathway","volume":"582","author":"Liu","year":"2008","journal-title":"FEBS Lett."},{"key":"2026101320065187600_RSOB260040C46","doi-asserted-by":"crossref","first-page":"9813","DOI":"10.1074\/jbc.M409745200","article-title":"A central role for the Hsp90.Cdc37 molecular chaperone module in interleukin-1 receptor-associated-kinase-dependent signaling by toll-like receptors","volume":"280","author":"De Nardo","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2026101320065187600_RSOB260040C47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.imlet.2007.12.017","article-title":"Innate immunity meets with cellular stress at the IKK complex: regulation of the IKK complex by Hsp70 and Hsp90","volume":"117","author":"Salminen","year":"2008","journal-title":"Immunol. Lett."},{"key":"2026101320065187600_RSOB260040C48","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/15376516.2012.673091","article-title":"Mechanism of JNK signal regulation by placental Hsp70 and Hsp90 in endothelial cell during preeclampsia","volume":"22","author":"Padmini","year":"2012","journal-title":"Toxicol. Mech. Methods"},{"key":"2026101320065187600_RSOB260040C49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12958-021-00723-2","article-title":"Hsp90 modulates human sperm capacitation via the Erk1\/2 and p38 MAPK signaling pathways","volume":"19","author":"Sun","year":"2021","journal-title":"Reprod. Biol. Endocrinol."},{"key":"2026101320065187600_RSOB260040C50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12010021","article-title":"Chaperoning STAT3\/5 by heat shock proteins: interest of their targeting in cancer therapy","volume":"12","author":"Jego","year":"2019","journal-title":"Cancers"},{"key":"2026101320065187600_RSOB260040C51","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/iub.607","article-title":"STAT3 interacts directly with Hsp90","volume":"64","author":"Prinsloo","year":"2012","journal-title":"IUBMB Life"},{"key":"2026101320065187600_RSOB260040C52","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1158\/1535-7163.MCT-16-0848","article-title":"Inhibition of Hsp90 suppresses PI3K\/AKT\/mTOR signaling and has antitumor activity in Burkitt Lymphoma","volume":"16","author":"Giulino-Roth","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"2026101320065187600_RSOB260040C53","doi-asserted-by":"crossref","first-page":"10 832\u201310 837","DOI":"10.1073\/pnas.170276797","article-title":"Modulation of Akt kinase activity by binding to Hsp90","volume":"97","author":"Sato","year":"2000","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026101320065187600_RSOB260040C54","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1128\/MCB.01246-12","article-title":"Canonical and kinase activity-independent mechanisms for extracellular signal-regulated kinase 5 (ERK5) nuclear translocation require dissociation of Hsp90 from the ERK5-Cdc37 complex","volume":"33","author":"Erazo","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"2026101320065187600_RSOB260040C55","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2016-12-753152","article-title":"Hsp90, a chaperone that can make you SYK","volume":"129","author":"Ten Hacken","year":"2017","journal-title":"Blood"},{"key":"2026101320065187600_RSOB260040C56","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1091\/mbc.e05-09-0853","article-title":"Hsp90 regulates activation of interferon regulatory factor 3 and TBK-1 stabilization in Sendai virus-infected cells","volume":"17","author":"Yang","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"2026101320065187600_RSOB260040C57","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1080\/15548627.2025.2481661","article-title":"TBK1 is a signaling hub in coordinating stress-adaptive mechanisms in head and neck cancer progression","volume":"21","author":"Kim","year":"2025","journal-title":"Autophagy."},{"key":"2026101320065187600_RSOB260040C58","doi-asserted-by":"crossref","first-page":"9165","DOI":"10.1038\/sj.onc.1207179","article-title":"Stability of the Peutz-Jeghers syndrome kinase LKB1 requires its binding to the molecular chaperones Hsp90\/Cdc37","volume":"22","author":"Nony","year":"2003","journal-title":"Oncogene"},{"key":"2026101320065187600_RSOB260040C59","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/02656736.2016.1256503","article-title":"Hsp90 inhibitors in the context of heat shock and the unfolded protein response: effects on a primary canine pulmonary adenocarcinoma cell line","volume":"33","author":"Graner","year":"2017","journal-title":"Int. J. Hyperthermia"},{"key":"2026101320065187600_RSOB260040C60","doi-asserted-by":"crossref","first-page":"10 346\u201310 353","DOI":"10.1074\/jbc.M106736200","article-title":"Involvement of Hsp90 in signaling and stability of 3-phosphoinositide-dependent kinase-1","volume":"277","author":"Fujita","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2026101320065187600_RSOB260040C61","doi-asserted-by":"crossref","first-page":"3 507 290","DOI":"10.1155\/2016\/3507290","article-title":"Inhibition of Hsp90 promotes neural stem cell survival from oxidative stress through attenuating NF-kappaB\/p65 activation","volume":"2016","author":"Liu","year":"2016","journal-title":"Oxid. Med. Cell. Longevity"},{"key":"2026101320065187600_RSOB260040C62","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0014-5793(99)01359-9","article-title":"Hypoxia-induced activation of HIF-1: role of HIF-1alpha-Hsp90 interaction","volume":"460","author":"Minet","year":"1999","journal-title":"FEBS Lett."},{"key":"2026101320065187600_RSOB260040C63","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1186\/1471-2407-10-668","article-title":"Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition","volume":"10","author":"Hackl","year":"2010","journal-title":"BMC Cancer"},{"key":"2026101320065187600_RSOB260040C64","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.omtn.2021.06.021","article-title":"CircSTK40 contributes to recurrent implantation failure via modulating the Hsp90\/AKT\/FOXO1 axis","volume":"26","author":"Ni","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2026101320065187600_RSOB260040C65","doi-asserted-by":"crossref","first-page":"115 505","DOI":"10.1016\/j.bcp.2023.115505","article-title":"Heat shock proteins and cancer: the FoxM1 connection","volume":"211","author":"Alimardan","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"2026101320065187600_RSOB260040C66","doi-asserted-by":"crossref","first-page":"11 568","DOI":"10.1074\/jbc.A110.175802","article-title":"Hsp90 interaction with INrf2(Keap1) mediates stress-induced Nrf2 activation","volume":"289","author":"Niture","year":"2014","journal-title":"J. Biol. Chem."},{"key":"2026101320065187600_RSOB260040C67","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1042\/BST20210370","article-title":"Extracellular Hsp90 and protection of neuronal cells through Nrf2","volume":"49","author":"Calderwood","year":"2021","journal-title":"Biochem. Soc. Trans."},{"key":"2026101320065187600_RSOB260040C68","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/cdd.2013.129","article-title":"Hsp90 chaperones PPARgamma and regulates differentiation and survival of 3T3-L1 adipocytes","volume":"20","author":"Nguyen","year":"2013","journal-title":"Cell Death Differ."},{"key":"2026101320065187600_RSOB260040C69","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1021\/acschembio.1c00788","article-title":"Development and efficacy of an orally bioavailable selective TAK1 inhibitor for the treatment of inflammatory arthritis","volume":"17","author":"Scarneo","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"2026101320065187600_RSOB260040C70","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1172\/jci.insight.165358","article-title":"Pharmacological inhibition of TAK1 prevents and induces regression of experimental organ fibrosis","volume":"8","author":"Bale","year":"2023","journal-title":"JCI Insight."},{"key":"2026101320065187600_RSOB260040C71","doi-asserted-by":"crossref","first-page":"200 099","DOI":"10.1098\/rsob.200099","article-title":"TAK1: a potent tumour necrosis factor inhibitor for the treatment of inflammatory diseases","volume":"10","author":"Totzke","year":"2020","journal-title":"Open Biol."},{"key":"2026101320065187600_RSOB260040C72","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.1038\/sj.onc.1207705","article-title":"Requirement of Hsp90 activity for IkappaB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-kappaB activation","volume":"23","author":"Broemer","year":"2004","journal-title":"Oncogene"},{"key":"2026101320065187600_RSOB260040C73","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1097-2765(02)00450-1","article-title":"TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90","volume":"9","author":"Chen","year":"2002","journal-title":"Mol. Cell"},{"key":"2026101320065187600_RSOB260040C74","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1158\/0008-5472.CAN-09-0448","article-title":"JNK1 mediates degradation HIF-1alpha by a VHL-independent mechanism that involves the chaperones Hsp90\/Hsp70","volume":"70","author":"Zhang","year":"2010","journal-title":"Cancer Res."},{"key":"2026101320065187600_RSOB260040C75","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.freeradbiomed.2004.08.017","article-title":"Dual role of cAMP in iNOS expression in glial cells and macrophages is mediated by differential regulation of p38-MAPK\/ATF-2 activation and iNOS stability","volume":"37","author":"Won","year":"2004","journal-title":"Free Radical Biol. Med."},{"key":"2026101320065187600_RSOB260040C76","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1038\/sj.onc.1203525","article-title":"Complex roles of Stat1 in regulating gene expression","volume":"19","author":"Ramana","year":"2000","journal-title":"Oncogene"},{"key":"2026101320065187600_RSOB260040C77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.05.001","article-title":"STAT3 signaling in immunity","volume":"31","author":"Hillmer","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"2026101320065187600_RSOB260040C78","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1089\/jir.2015.0054","article-title":"STAT5 in cancer and immunity","volume":"36","author":"Rani","year":"2016","journal-title":"J. Interferon Cytokine Res."},{"key":"2026101320065187600_RSOB260040C79","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1093\/emboj\/18.17.4754","article-title":"STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells","volume":"18","author":"Nosaka","year":"1999","journal-title":"EMBO J."},{"key":"2026101320065187600_RSOB260040C80","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cellsig.2017.07.014","article-title":"Hsp90 is necessary for the ACK1-dependent phosphorylation of STAT1 and STAT3","volume":"39","author":"Mahendrarajah","year":"2017","journal-title":"Cell Signal."},{"key":"2026101320065187600_RSOB260040C81","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.cellsig.2010.03.012","article-title":"Stat1 mediates an auto-regulation of Hsp90beta gene in heat shock response","volume":"22","author":"Cheng","year":"2010","journal-title":"Cell Signal."},{"key":"2026101320065187600_RSOB260040C82","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/labinvest.3700027","article-title":"Hypoxia increases Hsp90 binding to eNOS via PI3K-akt in porcine coronary artery endothelium","volume":"84","author":"Chen","year":"2004","journal-title":"Lab. Invest."},{"key":"2026101320065187600_RSOB260040C83","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.4049\/jimmunol.1601515","article-title":"Akt signaling pathway in macrophage activation and M1\/M2 polarization","volume":"198","author":"Vergadi","year":"2017","journal-title":"J. Immunol."},{"key":"2026101320065187600_RSOB260040C84","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1349-7006.2011.02181.x","article-title":"HIF-1alpha and Hsp90: target molecules selected from a tumorigenic papillary thyroid carcinoma cell line","volume":"103","author":"Mo","year":"2012","journal-title":"Cancer Sci."},{"key":"2026101320065187600_RSOB260040C85","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1128\/MCB.24.13.5667-5676.2004","article-title":"Regulation of the Src family kinase Lck by Hsp90 and ubiquitination","volume":"24","author":"Giannini","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"2026101320065187600_RSOB260040C86","doi-asserted-by":"crossref","first-page":"13 451\u201313 459","DOI":"10.1021\/bi961332c","article-title":"Hsp90-mediated folding of the lymphoid cell kinase p56lck","volume":"35","author":"Hartson","year":"1996","journal-title":"Biochemistry"},{"key":"2026101320065187600_RSOB260040C87","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bbrc.2006.12.211","article-title":"Intermolecular relations between the glucocorticoid receptor, ZAP-70 kinase, and hsp-90","volume":"354","author":"Bartis","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2026101320065187600_RSOB260040C88","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.molcel.2006.07.016","article-title":"Structure of an Hsp90-Cdc37-Cdk4 complex","volume":"23","author":"Vaughan","year":"2006","journal-title":"Mol. Cell"},{"key":"2026101320065187600_RSOB260040C89","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1126\/science.aaf5023","article-title":"Atomic structure of Hsp90-Cdc37-Cdk4 reveals that Hsp90 traps and stabilizes an unfolded kinase","volume":"352","author":"Verba","year":"2016","journal-title":"Science"},{"key":"2026101320065187600_RSOB260040C90","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.celrep.2017.10.042","article-title":"Differential regulation of G1 CDK complexes by the Hsp90-Cdc37 chaperone system","volume":"21","author":"Hallett","year":"2017","journal-title":"Cell Rep."},{"key":"2026101320065187600_RSOB260040C91","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13045-021-01039-9","article-title":"Preclinical evaluation of the Hsp90 inhibitor SNX-5422 in ibrutinib resistant CLL","volume":"14","author":"Chen","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"2026101320065187600_RSOB260040C92","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1182\/blood-2016-06-721423","article-title":"Hsp90 promotes Burkitt lymphoma cell survival by maintaining tonic B-cell receptor signaling","volume":"129","author":"Walter","year":"2017","journal-title":"Blood"},{"key":"2026101320065187600_RSOB260040C93","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/cr.2007.47","article-title":"Hsp90 regulates processing of NF-kappa B2 p100 involving protection of NF-kappa B-inducing kinase (NIK) from autophagy-mediated degradation","volume":"17","author":"Qing","year":"2007","journal-title":"Cell Res."},{"key":"2026101320065187600_RSOB260040C94","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.2147\/OTT.S245813","article-title":"Hsp90 Inhibitor ganetespib (STA-9090) inhibits tumor growth in c-myc-dependent esophageal squamous cell carcinoma","volume":"13","author":"Guan","year":"2020","journal-title":"OncoTargets Ther."},{"key":"2026101320065187600_RSOB260040C95","doi-asserted-by":"crossref","first-page":"e0160312","DOI":"10.1371\/journal.pone.0160312","article-title":"Systematic proteomic identification of the heat shock proteins (Hsp) that interact with estrogen receptor alpha (ERalpha) and biochemical characterization of the ERalpha-Hsp70 interaction","volume":"11","author":"Dhamad","year":"2016","journal-title":"PLoS ONE"},{"key":"2026101320065187600_RSOB260040C96","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.toxlet.2014.01.032","article-title":"Potential role of Hsp90 in mediating the interactions between estrogen receptor (ER) and aryl hydrocarbon receptor (AhR) signaling pathways","volume":"226","author":"Chang","year":"2014","journal-title":"Toxicol. Lett."},{"key":"2026101320065187600_RSOB260040C97","doi-asserted-by":"crossref","first-page":"11 928","DOI":"10.1016\/S0021-9258(19)38489-3","article-title":"Mapping the Hsp90 binding region of the glucocorticoid receptor","volume":"265","author":"Howard","year":"1990","journal-title":"J. Biol. Chem."},{"key":"2026101320065187600_RSOB260040C98","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.cell.2014.04.038","article-title":"Glucocorticoid receptor function regulated by coordinated action of the Hsp90 and Hsp70 chaperone cycles","volume":"157","author":"Kirschke","year":"2014","journal-title":"Cell"},{"key":"2026101320065187600_RSOB260040C99","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1189\/jlb.5A0814-413R","article-title":"Combined PI3K\/Akt and Hsp90 targeting synergistically suppresses essential functions of alloreactive T cells and increases Tregs","volume":"98","author":"Berges","year":"2015","journal-title":"J. Leukoc Biol."},{"key":"2026101320065187600_RSOB260040C100","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.molimm.2010.12.014","article-title":"Hsp90 is crucial for regulation of LAT expression in activated T cells","volume":"48","author":"Hayashi","year":"2011","journal-title":"Mol. Immunol."},{"key":"2026101320065187600_RSOB260040C101","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1074-7613(00)80184-3","article-title":"Lck activity controls CD4\/CD8 T cell lineage commitment","volume":"12","author":"Hernandez-Hoyos","year":"2000","journal-title":"Immunity"},{"key":"2026101320065187600_RSOB260040C102","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1177\/1947601913478972","article-title":"CDK4: a key player in the cell cycle, development, and cancer","volume":"3","author":"Baker","year":"2012","journal-title":"Genes Cancer"},{"key":"2026101320065187600_RSOB260040C103","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1161\/CIRCRESAHA.109.213769","article-title":"Specific regulation of noncanonical p38alpha activation by Hsp90-Cdc37 chaperone complex in cardiomyocyte","volume":"106","author":"Ota","year":"2010","journal-title":"Circ. Res."},{"key":"2026101320065187600_RSOB260040C104","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/cmi.2017.167","article-title":"Lymphatic endothelial cells regulate B-cell homing to lymph nodes via a NIK-dependent mechanism","volume":"16","author":"Yang","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"2026101320065187600_RSOB260040C105","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1182\/blood-2016-04-711176","article-title":"Hsp90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma","volume":"128","author":"Jacobson","year":"2016","journal-title":"Blood"},{"key":"2026101320065187600_RSOB260040C106","first-page":"1059","article-title":"Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling","volume":"63","author":"Chen","year":"2003","journal-title":"Cancer Res."},{"key":"2026101320065187600_RSOB260040C107","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.molcel.2005.04.021","article-title":"HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor","volume":"18","author":"Kovacs","year":"2005","journal-title":"Mol. Cell."},{"key":"2026101320065187600_RSOB260040C108","doi-asserted-by":"crossref","first-page":"18487","DOI":"10.1073\/pnas.0609163103","article-title":"Unliganded and hormone-bound glucocorticoid receptors interact with distinct hydrophobic sites in the Hsp90 C-terminal domain","volume":"103","author":"Fang","year":"2006","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026101320065187600_RSOB260040C109","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3892\/br.2012.42","article-title":"TNF inhibitor therapy for rheumatoid arthritis","volume":"1","author":"Ma","year":"2013","journal-title":"Biomed Rep"},{"key":"2026101320065187600_RSOB260040C110","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s40265-017-0829-7","article-title":"Tocilizumab: a review in rheumatoid arthritis","volume":"77","author":"Scott","year":"2017","journal-title":"Drugs"},{"key":"2026101320065187600_RSOB260040C111","doi-asserted-by":"crossref","first-page":"1 577 628","DOI":"10.3389\/fphar.2025.1577628","article-title":"Blockade of IL-1 family cytokines in the treatment of rheumatoid arthritis","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"2026101320065187600_RSOB260040C112","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0006-291X(02)02941-8","article-title":"Involvement of heat-shock protein 90 in the interleukin-6-mediated signaling pathway through STAT3","volume":"300","author":"Sato","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2026101320065187600_RSOB260040C113","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1158\/1078-0432.CCR-07-1104","article-title":"Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6\/signal-transducer and activator of transcription 3\/hypoxia-inducible factor-1alpha autocrine loop, and reduces orthotopic tumor growth","volume":"13","author":"Lang","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"2026101320065187600_RSOB260040C114","doi-asserted-by":"crossref","first-page":"eadk3663","DOI":"10.1126\/sciadv.adk3663","article-title":"Hsp90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer","volume":"10","author":"Chen","year":"2024","journal-title":"Sci. Adv."},{"key":"2026101320065187600_RSOB260040C115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.tox.2018.01.006","article-title":"Nickel ions bind to Hsp90beta and enhance HIF-1alpha-mediated IL-8 expression","volume":"39","author":"Asakawa","year":"2018","journal-title":"Toxicology"},{"key":"2026101320065187600_RSOB260040C116","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s12192-014-0513-8","article-title":"Hsp90 blockade modulates bullous pemphigoid IgG-induced IL-8 production by keratinocytes","volume":"19","author":"Tukaj","year":"2014","journal-title":"Cell Stress Chaperones"},{"key":"2026101320065187600_RSOB260040C117","doi-asserted-by":"crossref","first-page":"1 289 788","DOI":"10.3389\/fimmu.2023.1289788","article-title":"Heat shock protein 90 inhibition attenuates inflammation in models of atopic dermatitis: a novel mechanism of action","volume":"14","author":"Ben Abdallah","year":"2023","journal-title":"Front. Immunol."},{"key":"2026101320065187600_RSOB260040C118","first-page":"4218","article-title":"Epithelial-derived gasdermin D mediates nonlytic IL-1beta release during experimental colitis","volume":"130","author":"Bulek","year":"2020","journal-title":"J. Clin. Invest."},{"key":"2026101320065187600_RSOB260040C119","doi-asserted-by":"crossref","first-page":"10519","DOI":"10.1074\/jbc.275.14.10519","article-title":"Disruption of Hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation","volume":"275","author":"Lewis","year":"2000","journal-title":"J. Biol. Chem."},{"key":"2026101320065187600_RSOB260040C120","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10753-023-01914-2","article-title":"Hsp90 exacerbates bone destruction in rheumatoid arthritis by activating TRAF6\/NFATc1 signaling","volume":"47","author":"Wang","year":"2024","journal-title":"Inflammation"},{"key":"2026101320065187600_RSOB260040C121","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2249.1995.tb08340.x","article-title":"Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)","volume":"101","author":"Maini","year":"1995","journal-title":"Clin. Exp. Immunol."},{"key":"2026101320065187600_RSOB260040C122","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1592\/phco.30.4.339","article-title":"Meta-analysis of the efficacy and safety of adalimumab, etanercept, and infliximab for the treatment of rheumatoid arthritis","volume":"30","author":"Wiens","year":"2010","journal-title":"Pharmacotherapy"},{"key":"2026101320065187600_RSOB260040C123","first-page":"67","article-title":"Cost-effectiveness of routine measuring of serum drug concentrations and anti-drug antibodies in treatment of rheumatoid arthritis patients with TNF-alpha blockers","volume":"10","author":"Laine","year":"2016","journal-title":"Biologics"},{"key":"2026101320065187600_RSOB260040C124","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/j.1471-4159.2006.04221.x","article-title":"The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis","volume":"99","author":"Dello Russo","year":"2006","journal-title":"J. Neurochem."},{"key":"2026101320065187600_RSOB260040C125","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/cmi.2012.5","article-title":"Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL\/lpr mouse model of systemic lupus erythematosus","volume":"9","author":"Shimp","year":"2012","journal-title":"Cell. Mol. Immunol."},{"key":"2026101320065187600_RSOB260040C126","doi-asserted-by":"crossref","first-page":"e0127361","DOI":"10.1371\/journal.pone.0127361","article-title":"The Hsp90 inhibitor ganetespib alleviates disease progression and augments intermittent cyclophosphamide therapy in the MRL\/lpr mouse model of systemic Lupus Erythematosus","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS ONE"},{"key":"2026101320065187600_RSOB260040C127","first-page":"728 605","article-title":"Role of Hsp90 in systemic lupus erythematosus and its clinical relevance","volume":"2012","author":"Shukla","year":"2012","journal-title":"Autoimmune Dis."},{"key":"2026101320065187600_RSOB260040C128","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2249.2002.01887.x","article-title":"Lupus-specific kidney deposits of Hsp90 are associated with altered IgG idiotypic interactions of anti-Hsp90 autoantibodies","volume":"129","author":"Kenderov","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"2026101320065187600_RSOB260040C129","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients","volume":"82","author":"Cervera","year":"2003","journal-title":"Medicine"},{"key":"2026101320065187600_RSOB260040C130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/jaut.2001.0549","article-title":"Elevated levels of the 90 kDa heat shock protein (Hsp90) in SLE correlate with levels of IL-6 and autoantibodies to Hsp90","volume":"17","author":"Ripley","year":"2001","journal-title":"J. Autoimmun."},{"key":"2026101320065187600_RSOB260040C131","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.MIB.0000442839.28664.75","article-title":"Targeted inhibition of heat shock protein 90 suppresses tumor necrosis factor-alpha and ameliorates murine intestinal inflammation","volume":"20","author":"Collins","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"2026101320065187600_RSOB260040C132","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3892\/ijmm.2016.2627","article-title":"Heat shock protein 90 is involved in IL-17-mediated skin inflammation following thermal stimulation","volume":"38","author":"Kim","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"2026101320065187600_RSOB260040C133","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ni.2479","article-title":"The psoriasis-associated D10N variant of the adaptor Act1 with impaired regulation by the molecular chaperone Hsp90","volume":"14","author":"Wang","year":"2013","journal-title":"Nat. Immunol."},{"key":"2026101320065187600_RSOB260040C134","doi-asserted-by":"crossref","first-page":"319","DOI":"10.5114\/ada.2021.106210","article-title":"Does Hsp90 play an important role in psoriasis?","volume":"38","author":"Czajkowski","year":"2021","journal-title":"Postepy Dermatol. Alergol."},{"key":"2026101320065187600_RSOB260040C135","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.trsl.2015.08.010","article-title":"Proinsulin and heat shock protein 90 as biomarkers of beta-cell stress in the early period after onset of type 1 diabetes","volume":"168","author":"Watkins","year":"2016","journal-title":"Transl. Res."},{"key":"2026101320065187600_RSOB260040C136","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0896-8411(03)00035-0","article-title":"Type 1 diabetes alters anti-Hsp90 autoantibody isotype","volume":"20","author":"Qin","year":"2003","journal-title":"J. Autoimmun."},{"key":"2026101320065187600_RSOB260040C137","first-page":"pp. 1\u201336","volume-title":"Inhibitors of molecular chaperones as therapeutic agents","author":"Wang","year":"2013"},{"key":"2026101320065187600_RSOB260040C138","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/exd.12760","article-title":"Heat shock protein 90: a pathophysiological factor and novel treatment target in autoimmune bullous skin diseases","volume":"24","author":"Tukaj","year":"2015","journal-title":"Exp. Dermatol."},{"key":"2026101320065187600_RSOB260040C139","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1021\/acscentsci.2c00013","article-title":"Development of a first-in-class small-molecule inhibitor of the C-terminal Hsp90 dimerization","volume":"8","author":"Bhatia","year":"2022","journal-title":"ACS Cent Sci."},{"key":"2026101320065187600_RSOB260040C140","doi-asserted-by":"crossref","first-page":"129111","DOI":"10.1016\/j.bmcl.2022.129111","article-title":"Recent advances toward the development of Hsp90 C-terminal inhibitors","volume":"80","author":"Amatya","year":"2023","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2026101320065187600_RSOB260040C141","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.2174\/092986708786242895","article-title":"Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket","volume":"15","author":"Donnelly","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"2026101320065187600_RSOB260040C142","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1074\/jbc.M111.309526","article-title":"The molecular chaperone gp96\/GRP94 interacts with toll-like receptors and integrins via its C-terminal hydrophobic domain","volume":"287","author":"Wu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"2026101320065187600_RSOB260040C143","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.immuni.2006.12.005","article-title":"Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages","volume":"26","author":"Yang","year":"2007","journal-title":"Immunity"},{"key":"2026101320065187600_RSOB260040C144","doi-asserted-by":"crossref","first-page":"1 005 045","DOI":"10.3389\/fimmu.2022.1005045","article-title":"Hsp90beta inhibition upregulates interferon response and enhances immune checkpoint blockade therapy in murine tumors","volume":"13","author":"Rahmy","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Open Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/royalsocietypublishing.org\/rsob\/article-pdf\/doi\/10.1098\/rsob.260040\/6170454\/rsob.260040.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/royalsocietypublishing.org\/rsob\/article-pdf\/doi\/10.1098\/rsob.260040\/6170454\/rsob.260040.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:07:13Z","timestamp":1791936433000},"score":1,"resource":{"primary":{"URL":"https:\/\/royalsocietypublishing.org\/rsob\/article\/16\/10\/260040\/483637\/Hsp90-as-a-master-regulator-in-autoimmunity-from"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":144,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,14]]}},"URL":"https:\/\/doi.org\/10.1098\/rsob.260040","relation":{},"ISSN":["2046-2441"],"issn-type":[{"value":"2046-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"article-number":"260040"}}